Researchers use AI to predict rare cancer immunotherapy responses

https://www.news-medical.net/news/20260630/Researchers-use-AI-to-predict-rare-cancer-immunotherapy-responses.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in a study of patients with rare cancers, published in the Journal for ImmunoTherapy of Cancer. Led by Aung Naing, M.D., professor of Investigational Cancer Therapeutics, this analysis builds on recently published research that identified features in the tumor microenvironment that were predictive of immunotherapy response in patients with rare cancers, even in those who did not have known markers of immunotherapy response.